Six ARBs are currently available in the United States for hypertension: losartan, valsartan, irbesartan, candesartan, eprosartan, and telmisartan (Table 1). All ARBs share certain features because ...

Several clinical trials have demonstrated the relative tolerability of losartan. [8,14,18,19,20] The most frequent adverse reaction, as observed in a clinical trial of 2900 patients assessing the ...

Arbli is supplied as an peppermint-flavored oral suspension containing 10mg/mL of losartan potassium in 165mL bottles. The Food and Drug Administration (FDA) has approved Arbli ™, an oral ...